000 | 01914 a2200589 4500 | ||
---|---|---|---|
005 | 20250514204702.0 | ||
264 | 0 | _c20050328 | |
008 | 200503s 0 0 eng d | ||
022 | _a0026-895X | ||
024 | 7 |
_a10.1124/mol.104.005553 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aErbe, David V | |
245 | 0 | 0 |
_aErtiprotafib improves glycemic control and lowers lipids via multiple mechanisms. _h[electronic resource] |
260 |
_bMolecular pharmacology _cJan 2005 |
||
300 |
_a69-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdipocytes _xcytology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Obese |
650 | 0 | 4 |
_aPPAR alpha _xgenetics |
650 | 0 | 4 |
_aPPAR gamma _xgenetics |
650 | 0 | 4 |
_aPhenylpropionates _xpharmacology |
650 | 0 | 4 | _aProtein Tyrosine Phosphatase, Non-Receptor Type 1 |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
650 | 0 | 4 |
_aThiophenes _xpharmacology |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aWang, Suyue | |
700 | 1 | _aZhang, Yan-Ling | |
700 | 1 | _aHarding, Kimberly | |
700 | 1 | _aKung, Leslie | |
700 | 1 | _aTam, May | |
700 | 1 | _aStolz, Leslie | |
700 | 1 | _aXing, Yuzhe | |
700 | 1 | _aFurey, Sarah | |
700 | 1 | _aQadri, Ariful | |
700 | 1 | _aKlaman, Lori D | |
700 | 1 | _aTobin, James F | |
773 | 0 |
_tMolecular pharmacology _gvol. 67 _gno. 1 _gp. 69-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.104.005553 _zAvailable from publisher's website |
999 |
_c15166953 _d15166953 |